Lee WR - Search Results

1

Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial.

Roach M, Moughan J, Lawton CAF, Dicker AP, Zeitzer KL, Gore EM, Kwok Y, Seider MJ, Hsu IC, Hartford AC, Horwitz EM, Yamoah K, Jones CU, Michalski JM, Lee WR, Pisansky TM, Rabinovitch R, Rotman M, Pryzant RM, Kim HE, Thomas CR Jr, Shipley WU, Sandler HM. Roach M, et al. Among authors: lee wr. Lancet Oncol. 2018 Nov;19(11):1504-1515. doi: 10.1016/S1470-2045(18)30528-X. Epub 2018 Oct 10. Lancet Oncol. 2018. PMID: 30316827 Free PMC article. Clinical Trial.

2

Conformal treatment of prostate cancer with improved targeting: superior prostate-specific antigen response compared to standard treatment.

Corn BW, Hanks GE, Schultheiss TE, Hunt MA, Lee WR, Coia LR. Corn BW, et al. Among authors: lee wr. Int J Radiat Oncol Biol Phys. 1995 May 15;32(2):325-30. doi: 10.1016/0360-3016(94)00618-U. Int J Radiat Oncol Biol Phys. 1995. PMID: 7503847

3

Early prostate cancer: the national results of radiation treatment from the Patterns of Care and Radiation Therapy Oncology Group studies with prospects for improvement with conformal radiation and adjuvant androgen deprivation.

Hanks GE, Hanlon A, Schultheiss T, Corn B, Shipley WU, Lee WR. Hanks GE, et al. Among authors: lee wr. J Urol. 1994 Nov;152(5 Pt 2):1775-80. doi: 10.1016/s0022-5347(17)32384-4. J Urol. 1994. PMID: 7523724 Clinical Trial.

4

Observations of pretreatment prostate-specific antigen doubling time in 107 patients referred for definitive radiotherapy.

Lee WR, Hanks GE, Corn BW, Schultheiss TE. Lee WR, et al. Int J Radiat Oncol Biol Phys. 1995 Jan 1;31(1):21-4. doi: 10.1016/0360-3016(94)00339-M. Int J Radiat Oncol Biol Phys. 1995. PMID: 7527798

5

Localized prostate cancer treated by external-beam radiotherapy alone: serum prostate-specific antigen--driven outcome analysis.

Lee WR, Hanks GE, Schultheiss TE, Corn BW, Hunt MA. Lee WR, et al. J Clin Oncol. 1995 Feb;13(2):464-9. doi: 10.1200/JCO.1995.13.2.464. J Clin Oncol. 1995. PMID: 7531222

6

Prostate cancer.

Lee WR, Giantonio B, Hanks GE. Lee WR, et al. Curr Probl Cancer. 1994 Nov-Dec;18(6):295-357. doi: 10.1016/0147-0272(94)90005-1. Curr Probl Cancer. 1994. PMID: 7536141 Review.

7

Prostate specific antigen density is not an independent predictor of response for prostate cancer treated by conformal radiotherapy.

Corn BW, Hanks GE, Lee WR, Bonin SR, Hudes G, Schultheiss T. Corn BW, et al. Among authors: lee wr. J Urol. 1995 Jun;153(6):1855-9. J Urol. 1995. PMID: 7538598

8

Localized carcinoma of the prostate (stages T1B, T1C, T2, and T3). Review of management with external beam radiation therapy.

Perez CA, Hanks GE, Leibel SA, Zietman AL, Fuks Z, Lee WR. Perez CA, et al. Among authors: lee wr. Cancer. 1993 Dec 1;72(11):3156-73. doi: 10.1002/1097-0142(19931201)72:11<3156::aid-cncr2820721106>3.0.co;2-g. Cancer. 1993. PMID: 7694785 Review.

9

Incidence of and factors related to late complications in conformal and conventional radiation treatment of cancer of the prostate.

Schultheiss TE, Hanks GE, Hunt MA, Lee WR. Schultheiss TE, et al. Among authors: lee wr. Int J Radiat Oncol Biol Phys. 1995 Jun 15;32(3):643-9. doi: 10.1016/0360-3016(95)00149-s. Int J Radiat Oncol Biol Phys. 1995. PMID: 7790250

10

Systematic biopsies: do they add prognostic information in men with clinically localized prostate cancer treated with radiation therapy alone?

Lee WR, Hanlon AL, Hanks GE. Lee WR, et al. Radiology. 1996 Feb;198(2):439-42. doi: 10.1148/radiology.198.2.8596846. Radiology. 1996. PMID: 8596846

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

911 results

Search Page